Kalendis Martiis 12th 2022, NMPA (SFDA) denuntiavit probans mutationem applicationis ad sui experimentum covidorum 19 antigenorum productorum Nanjing Vazyme Biotech Co, Ltd, Beijing Jinwofu Bioengineering Technologiae Co, Ltd, Shenzhen Huada Yinyuan Pharmaceutical. Technologia Co., Ltd, Guangzhou Wondfo B...
Read more